Citadel Advisors’s Electromed ELMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,100
Closed -$74K 13155
2025
Q1
$74K Buy
3,100
+300
+11% +$8.76K ﹤0.01% 11851
2024
Q4
$82.7K Sell
2,800
-900
-24% -$23.5K ﹤0.01% 11748
2024
Q3
$79.4K Sell
3,700
-600
-14% -$9.77K ﹤0.01% 11421
2024
Q2
$64.6K Buy
4,300
+2,200
+105% +$34.4K ﹤0.01% 11474
2024
Q1
$33.9K Buy
+2,100
New +$27.6K ﹤0.01% 12571
2023
Q1
Sell
-1,000
Closed -$10.5K 14888
2022
Q4
$10.5K Buy
+1,000
New +$10.2K ﹤0.01% 13617

Other funds holding ELMD

Citadel Advisors's ELMD Position: Q2 2026 in Review

Citadel Advisors increased its Electromed (ELMD) stake by 116% in Q2 2026, buying an estimated $724K and bringing the position to 42,045 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #6830.

Citadel Advisors first reported a position in ELMD in Q3 2013 and has held it in 21 quarters since. 128 funds tracked by Wall St. Rank hold ELMD as of Q2 2026.

  • Citadel Advisors held 42,045 shares of Electromed worth $1.78M as of Q2 2026.
  • Citadel Advisors bought 22,584 Electromed shares in Q2 2026, an estimated $724K.
  • Electromed made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6830 holding.
  • Citadel Advisors first reported a position in Electromed in Q3 2013 and has held it in 21 quarters since.
  • 128 funds tracked by Wall St. Rank held Electromed as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.